Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Scholar Rock Holding buy RudolfL

Start price
€14.90
06.02.24 / 50%
Target price
€19.00
26.05.24
Performance (%)
-6.71%
Price
€13.90
29.04.24
Summary
This prediction is currently active. With a performance of -6.71%, the BUY prediction for Scholar Rock Holding by RudolfL is down slightly. This prediction currently runs until 26.05.24. The prediction end date can be changed by RudolfL at any time. RudolfL has 50% into this prediction

Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.

Performance without dividends (%)
Name 1w 1m
Scholar Rock Holding 0.725% 0.725%
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by RudolfL for this prediction

In the thread Scholar Rock Holding diskutieren
Prediction Buy
Perf. (%) -6.71%
Target price 19.000
Change
Ends at 06.03.24

Kursziel gesetzt auf 19,0

Stopped prediction by RudolfL for Scholar Rock Holding

buy
Scholar Rock Holding

Start price
Target price
Perf. (%)
€9.05
22.08.22
€11.00
22.08.23
-31.49%
23.08.23

buy
Scholar Rock Holding

Start price
Target price
Perf. (%)
€25.60
14.06.21
€32.00
14.06.22
-32.03%
17.01.22